SkylineDx Molecular Test Outperforms Traditional Risk Factors for Melanoma
By Karen Roman SkylineDx said it published new peer-reviewed data where its Merlin CP-GEP Test...
Editorial
AlphaTON Capital: Capture the Best of Telegram Economics at a Steep Discount – Initiation Report
Download the Complete Report Here By Brandon Hornback Seeking a stock-market bargain to brighten the...
Capital Markets Outlook 2026: ICR Managing Partner Steve Parish, Live at NYSE
IPO Edge hosted a fireside chat on Dec. 9 from the floor of the New...
SOL Strategies: The Premier Public Play on the Solana Economy – Initiation Report
Download the Complete Report Here By Brandon Hornback SOL Strategies Inc. (NASDAQ: STKE) is the...
Vinson & Elkins Advises Coterra Energy on Power Purchase Agreement with PROPWR
By Exec Edge Editorial Staff Vinson & Elkins advised Coterra Energy Inc. on a behind-the-meter...
REX: 21 Profitable Quarters in a Row and Expansion Momentum Ahead — Quarterly Update Report
Download the Complete Report Here By Brandon Hornback REX American Resources Corp. (NYSE: REX) continued...
Sequana Medical Implants 1st FDA-Approved Medical Device For Liver Treatment
By Karen Roman Sequana Medical NV (BRU: SEQUA.BR) said it successfully implanted the alfapump device...
March Biosciences CAR-T Therapy Expectations and Phase 1 Experience
By Daniella Parra March Bio is developing MB-105, a first-in-class autologous CD5-targeted CAR-T cell therapy for...
Beyond WebMD: DxCheck CEO Chris Searles & CTO Trevor Smith, Live at Nasdaq
Exec Edge hosted a fireside chat on Dec. 8 from the Nasdaq Marketsite with Chris...
Public Gateway to Telegram Economy: AlphaTON Executive Chairman Enzo Villani, Live at Nasdaq
Exec Edge hosted a fireside chat on Dec. 8 at Nasdaq MarketSite with Enzo Villani,...
© Copyright 2025, ExecEdge